IBEX sales chief sells 17,474 shares at $40.41

IBEX’s Chief Sales/Marketing Officer reported an open-market sale of 17,474 shares, retaining 100,814 shares directly.

Rhea-AI Filing Summary

IBEX Ltd (IBEX) reported that Chief Sales/Marketing Officer Julie K. Casteel sold 17,474 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.41 per share. After this sale, she directly holds 100,814 Common Shares. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Seller: 17,474 shares

Net Sell 1 txn

Insider Casteel Julie K

Role Chief Sales/Marketing Officer

Sold 17,474 shs ($706K)

Type	Security	Shares	Price	Value
Sale	Common Shares F1	17,474	$40.4066	$706K

Holdings After Transaction: Common Shares — 100,814 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $40.16 to $40.64; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 17,474 shares Weighted average sale price: $40.41 per share Shares held after transaction: 100,814 shares +1 more

4 metrics

Shares sold 17,474 shares Common Shares sold on September 15, 2026

Weighted average sale price $40.41 per share Multiple trades between $40.16 and $40.64

Shares held after transaction 100,814 shares Direct ownership after the reported sale

Price range of trades $40.16–$40.64 per share Execution range for the September 15, 2026 sale

Key Terms

weighted average sales price, open market or private transaction, Rule 10b5-1 trading plan

3 terms

weighted average sales price financial

"the price reported above reflects the weighted average sales price"

open market or private transaction financial

"Sale in open market or private transaction"

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 plan is reported for this transaction"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who from IBEX (IBEX) reported a transaction in this Form 4?

The reporting person is Julie K. Casteel, who serves as Chief Sales/Marketing Officer of IBEX Ltd.

How many IBEX (IBEX) shares did Julie K. Casteel sell?

Julie K. Casteel sold 17,474 Common Shares of IBEX Ltd in the reported transaction on September 15, 2026.

At what price were the IBEX (IBEX) shares sold in this Form 4?

The shares were sold at a weighted average sales price of $40.41 per share, based on multiple trades executed between $40.16 and $40.64.

How many IBEX (IBEX) shares does Julie K. Casteel hold after this sale?

Following the reported sale, Julie K. Casteel directly holds 100,814 Common Shares of IBEX Ltd.

Was the IBEX (IBEX) share sale under a Rule 10b5-1 trading plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan for this transaction; the related checkbox is not affirmed.

What does the footnote say about the IBEX (IBEX) sale prices?

The footnote states the transaction was executed in multiple trades at prices from $40.16 to $40.64, and the reported price is the weighted average sales price; detailed trade prices are available on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 05:45 PM Accepted by SEC EDGAR 09/16/2026 - 05:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Casteel Julie K

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales/Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/15/2026		S		17,474	D	$40.4066(1)	100,814	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $40.16 to $40.64; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)